Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

Two recent tools in the battle for weight loss have been showing incredible results: Semaglutide and Tirzepatide. Stephanie Davison from Skin Envy Non-Surgical Weight Loss Center, and Registered ...

Single dose of Vivani’s NPM-139 semaglutide implant led to nearly 20% weight loss in rats, suggesting once- or twice-yearly dosing. NPM-139 showed steady semaglutide release with potential for ...

A similar prohibition on copycat weight loss medications that contain the active ingredient semaglutide is scheduled to take effect as early as April 22. The FDA announced the updated guidance ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration ... of GLP-1 therapy “Products containing semaglutide generated $25 billion in 2024 and demand ...